New drug could be a breakthrough in treatment for killer TB, trial suggests
by Kat Lay, Global health correspondent from Science | The Guardian on (#71JV7)
Sorfequiline shows stronger action than existing treatments against illness that killed 1.23 million last year
A new treatment for tuberculosis could boost cure rates and shorten the time needed to treat the disease by months, trial results suggest.
Globally, an estimated 10.7 million people fell ill with TB last year and 1.23 million died from it.
Continue reading...